Hansen Medical, Inc., a global leader in intravascular robotics, today announced that it has recently filed 30 new patent applications with the U.S. Patent and Trademark Office relating to flexible medical robotics, based on research and development activities conducted by the Company.
With these new filings, Hansen Medical now owns or has exclusive rights to approximately 250 issued and pending patent applications relating to medical robotics, in addition to hundreds of other related patents and patent applications which the Company has the right to use under various third party license agreements.
"Thanks to our talented, innovative and dedicated engineers and scientists, the level of invention has never been higher at Hansen Medical than it is today," said Bruce Barclay, president and CEO of Hansen Medical. "These new patent applications relate to not only our core intravascular robotics technology, but also other possible clinical applications of our technology, and a number of different technical elements critical to the clinical success of medical robotics, including robotic systems, software, flexible instruments, sensing, navigation, and imaging. I am more confident than ever that our intellectual property portfolio, as supplemented by these new filings, will provide us an even stronger proprietary position for our current and future products, and increased potential to grow shareholder value, for years to come."
"The creativity consistently demonstrated by our technical teams, supported by our significant investment in R&D, which resulted in these new filings, has been exceptional," said Will Sutton, COO of Hansen Medical. "The Company has never filed this many new U.S. patent applications in a single year in its history, let alone this early in the year, making this accomplishment all the more impressive."